Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

Progress in Cardiovascular Diseases

Volumn 28, Issue 1, 1985, Pages 1-83

  Wigle, E Douglas ^a   Sasson, Zion ^a   Henderson, Mark A ^a   Ruddy, Terrence D ^a   Fulop, John ^a   Rakowski, Harry ^a   Williams, William G ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CARDIOMYOPATHY; CARDIOVASCULAR SYSTEM; DIAGNOSIS; DISEASE COURSE; ETIOLOGY; HEART; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SURVEY; THERAPY;

ANGIOGRAPHY; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOMEGALY; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOCARDITIS; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MOTION PICTURES; PERICARDIUM; SYSTOLE; TACHYCARDIA;

EID: 0022390809     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/0033-0620(85)90024-6     Document Type: Review

References (275)

1. Retrecissement cardiaque sous aortique
2. Retrecissement ventriculo-aortique
3. Ueber linksseitige muskulose conusstenosen
4. Functional obstruction of the left ventricle
5. Functional obstruction of the left ventricle
6. Asymmetrical hypertrophy of the heart in young adults
7. Subaortic stenosis: A revised concept of the disease
8. Familial muscular subaortic stenosis. An unrecognized form of “idiopathic heart disease” with clinical and autopsy observations
9. Idiopathic hypertrophic subaortic stenosis
10. Idiopathic hypertrophic subaortic stenosis
11. Obstructive cardiomyopathy simulating aortic stenosis
12. Hereditary cardiovascular dysplasia
13. Subaortic stenosis produced by an abnormally placed anterior mitral leaflet
14. The clinical, hemodynamic and pathological diagnosis of muscular subvalvular aortic stenosis
15. Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis
16. Idiopathic hypertrophic subaortic stenosis: I. Description of the disease based upon an analysis of 64 patients
17. Idiopathic hypertrophic subaortic stenosis: I. Description of the disease based upon an analysis of 64 patients
18. Muscular subaortic stenosis: The clinical syndrome with additional evidence of ventricular septal hypertrophy
19. Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs
20. Demonstration of the dynamic nature of idiopathic hypertrophic subaortic stenosis
21. Muscular subaortic stenosis: The effect of peripheral vasodilatation
22. Studies on digitalis. V. Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis
23. Muscular subaortic stenosis. The interrelation of wall tension, outflow tract “distending pressure” and orifice radius
24. Muscular subaortic stenosis: The initial left ventricular inflow tract pressure as evidence of outflow tract obstruction
25. Muscular subaortic stenosis. Initial left ventricular inflow tract pressure in the assessment of intraventricular pressure differences in man
26. Mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis
27. Pressure gradients without obstruction. A new concept of “hypertrophic subaortic stenosis.”
28. Isometric contraction in late systole—a new explanation for the intraventricular pressure differences in idiopathic hypertrophic subaortic stenosis (IHSS)
29. Asymmetric septal hypertrophy and myocardial fiber disarray: Features of normal, developing and malformed hearts
30. Disproportionate ventricular septal thickening in the developing normal human heart
31. The asymmetrically hypertrophied septum. Further differentiation of its causes
32. Hypertrophic obstructive cardiomyopathy in infants of diabetic mothers
33. Echocardiographic measurements of left ventricular wall thickness in weight lifters: A problem with the definition of ASH
34. Echocardiographic features of primary pulmonary hypertension
35. Asymmetric septal hypertrophy in chronic hemodialysis patients
36. Congenital heart malformations associated with disproportionate ventricular septal thickening
37. Prevalence and characteristics of disproportionate ventricular septal thickening in patients with coronary artery disease
38. Inferior myocardial infarction. A common cause of asymmetric septal hypertrophy
39. Echocardiography in the diagnosis of idiopathic hypertrophic subaortic stenosis co-existing with aortic valve disease
40. Asymmetric septal hypertrophy in patients with aortic stenosis: An adaptive mechanism or a coexistence of hypertrophic cardiomyopathy?
41. Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy
42. Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis
43. Echocardiographic assessment of the effects of surgery and propranolol on the dynamics of outflow obstruction in hypertrophic subaortic stenosis
44. Ultrasound in the diagnosis and evaluation of therapy of idiopathic hypertrophic subaortic stenosis
45. Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis
46. Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis)
47. Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: Asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet
48. Anatomic variations in subgroups of hypertrophic cardiomyopathy as assessed by wide-angle two-dimensional echocardiography
49. Idiopathic hypertrophic subaortic stenosis viewed by wide-angle, phased-array echocardiography
50. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy
51. Cardiomyopathy: Predictions for the foreseeable future
52. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study
53. Latent muscular subaortic stenosis: A less severe form of hypertrophic cardiomyopathy
54. Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis
55. Hypertrophic cardiomyopathy: Subclassification by M mode echocardiography
56. Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy. An echocardiographic study
57. Muscular subaortic stenosis: The temporal relationship between systolic anterior motion of the anterior mitral leaflet and pressure gradient
58. Muscular subaortic stenosis: The quantitative relationship between systolic anterior motion and the pressure gradient
59. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy
60. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
61. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: Pressure-volume analysis with a nonimaging scintillation probe
62. Regional left ventricular asynchrony and impaired global left ventricular diastolic filling in hypertrophic cardiomyopathy: Effect of verapamil
63. Dynamic pressure-volume alterations during left ventricular ejection in hypertrophic cardiomyopathy: Evidence for true obstruction to left ventricular outflow
64. Acute effects of nifedipine therapy on left ventricular function at rest and during exercise in patients with nonobstructive hypertrophic cardiomyopathy
65. Hypertrophic obstructive cardiomyopathy Assessment by echocardiographic and Doppler ultrasound techniques
66. Idiopathic Hypertrophic Subaortic Stenosis: Combined Doppler and echocardiographic assessment
67. Echocardiographic and Doppler flow observations in idiopathic hypertrophic subaortic stenosis (IHSS)
68. Doppler aortic blood flow studies in obstructive and nonobstructive hypertrophic cardiomyopathy
69. Mitral regurgitation in hypertrophic cardiomyopathy. Non-invasive study by two-dimensional Doppler echocardiography
70. Doppler aortic velocity flow profiles in hypertrophic obstructive cardiomyopathy
71. Pressure-flow studies in hypertrophic subaortic stenosis
72. Idiopathic hypertrophic subaortic stenosis III Intraoperative studies of the mechanism of obstruction and its hemodynamic consequences
73. Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy
74. Pharmacodynamics of mitral insufficiency in muscular subaortic stenosis
75. Mitral regurgitation in muscular subaortic stenosis
76. Pathophysiological consideration in muscular subaortic stenosis
77. Medical and surgical treatment of cardiomyopathies
78. Medical and surgical treatment of cardiomyopathies
79. The variable nature of mitral regurgitation in muscular subaortic stenosis
80. Cardiovascular drugs in muscular subaortic stenosis
81. The clinical course in muscular subaortic stenosis: A retrospective and prospective study of 60 hemodynamically proved cases
82. Patterns of inheritance in hypertrophic cardiomyopathy: Assessment by M-mode and two-dimensional echocardiography
83. Coexistence of asymmetric and symmetric left ventricular hypertrophy in a family with hypertrophic cardiomyopathy
84. “Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death
85. Hypertrophic cardiomyopathy and human leukocyte antigen linkage. Differentiation of two forms of hypertrophic cardiomyopathy
86. HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy
87. HLA complex in hypertrophic cardiomyopathy
88. Left ventricular outflow tract obstruction due to systolic anterior motion of the anterior mitral leaflet in patients with concentric left ventricular hypertrophy
89. Giant negative T-wave inversion as a manifestation of asymmetric apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasonocardiotomographic study
90. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients
91. Apical hypertrophic cardiomyopathy
92. Apical hypertrophic cardiomyopathy in American patients
93. Apical hypertrophic cardiomyopathy: Evaluation by noninvasive and invasive techniques in 23 patients
94. Midventricular obstruction: A variant of obstructive cardiomyopathy
95. Midventricular obstruction in hypertrophic obstructive cardiomyopathy. New diagnostic and therapeutic challenge
96. Hypertrophic cardiomyopathy with midventricular obstruction associated with mitral stenosis: Partial relief of the obstruction by papillary muscle and trabecular resection
97. Midventricular obstruction with apical infarction and aneurysm formation
98. The current status of myocardial disarray in hypertrophic cardiomyopathy
99. Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: Relation between the two and significance
100. Myocardial Disarray Revisited
101. Muscle fiber disarray in common heart disease
102. Myocardial disarray A critical review
103. Isometric cardiac contraction: A possible cause of the disorganized myocardial pattern of idiopathic hypertrophic subaortic stenosis
104. Congenital heart disease associated with hypertrophic cardiomyopathy
105. Catenoid shape of the interventricular septum: Possible cause of idiopathic hypertrophic subaortic stenosis
106. Myocardial fiber disarray and ventricular septal hypertrophy in asymmetrical hypertrophy of the heart
107. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy
108. Myocardial disorganisation in hypertrophic cardiomyopathy. Another point of view
109. Myocyte disarray develops in papillary muscles released from normal tension after mitral valve replacement
110. Prospects and predictions for the cardiomyopathies
111. Cardiomyopathy: An interface between fundamental and clinical cardiology, Tokyo
112. Pathogenesis of hypertrophic cardiomyopathy: Hypotheses and speculations
113. Intracellular calcium levels during contraction and relaxation of mammalian cardiac vascular smooth muscle as detected with aequorin
114. Electrophoretic profiles of nonhistone nuclear proteins of human hearts with muscular subaortic stenosis
115. Nuclear proteins in the heart of cardiomyopathic Syrian hamster—fractionation of phenol soluble nonhistone proteins by two-dimensional polyacrylamide gel electrophoresis
116. Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study
117. Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study
118. Hypertrophic cardiomyopathy after aortic valve replacement
119. Magnetic resonance imaging (MRI) of hypertrophic cardiomyopathy
120. Hypertrophic obstructive cardiomyopathy
121. The effect of negative intrathoracic pressure on the outflow tract gradient in muscular subaortic stenosis
122. Muscular subaortic stenosis (hypertrophic obstructive cardiomyopathy): The evidence for true obstruction to left ventricular outflow
123. A hemodynamic technique for the detection of hypertrophic subaortic stenosis
124. Hypertrophic obstructive cardiomyopathy (muscular or hypertrophic subaortic stenosis)
125. Systolic anterior motion of the posterior mitral leaflet: A previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy
126. Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: A two-dimensional echocardiographic assessment
127. Mitral value systolic anterior motion in the absence of hypertrophic cardiomyopathy
128. Systolic anterior motion in the absence of asymmetric septal hypertrophy. A buckling phenomenon of the chordae tendineae
129. Morphology of the human mitral valve. II. The valve leaflets
130. Normal ventricular ejection dynamics in man during rest and exercise
131. Dynamic aortic valve gradients in hypertrophic cardiomyopathy (HCM)
132. Mitral regurgitation in idiopathic hypertrophic subaortic stenosis
133. Angiographic anatomy of the left ventricle and mitral valve in idiopathic hypertrophic subaortic stenosis
134. Left ventricular cineangiographic observations in muscular subaortic stenosis
135. L'insuffiacance mitrale dans la cardiomyopathie obstructive
136. The significance of systolic anterior motion (SAM) on the mitral valve echo pattern in hypertrophic cardiomyopathy
137. Anterior-superior displacement of papillary muscles producing obstruction and mitral regurgitation in idiopathic hypertrophic subaortic stenosis
138. Hypertrophic Cardiomyopathy
139. Enhanced ventricular emptying in the presence of a pressure gradient. A hemodynamic angiocardiographic study of hypertrophic cardiomyopathy
140. Abnormal mitral valve coaptation in hypertrophic obstructive cardiomyopathy: Proposed role in systolic anterior motion of mitral valve
141. Left ventricular outflow obstruction: A complication of mitral valvuloplasty
142. Surgery in muscular subaortic stenosis
143. Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M-mode and two-dimensional echocardiographic assessment
144. Post ventriculomyectomy eccentric SAM: Further evidence for the Venturi mechanism
145. Hypercontractile cardiac states simulating hypertrophic cardiomyopathy
146. Systolic anterior motion of the mitral valve without asymmetric septal hypertrophy
147. Cineangiographic timing of left ventricular outflow obstruction and systolic emptying in muscular subaortic stenosis
148. Muscular subaortic stenosis: The direct relation between the intraventricular pressure difference and left ventricular ejection time
149. Hypertrophic subaortic stenosis: Clinical and hemodynamic studies with special reference to pulse contour measurement
150. Isovolumic relaxation period in hypertrophic cardiomyopathy
151. The arterial pressure pulse in muscular subaortic stenosis
152. Dual control of relaxation. Its role in the ventricular function in the mammalian heart
153. Triple control of relaxation: Implications in cardiac disease
154. Hypertrophic cardiomyopathy: A disease in search of its own identity
155. The frontiers of cardiomyopathy
156. The effects of intraventricular gradients on left ventricular ejection dynamics
157. Does outflow obstruction exist in hypertrophic cardiomyopathy?
158. Evidence in circulatory shock of an isometric phase of ventricular contraction following ejection
159. Cineangiography in hemorrhagic shock
160. Clinical pharmacology of hypertrophic obstructive cardiomyopathy
161. Diagnosis of hypertrophic subaortic stenosis with a Doppler velocity detector
162. Results of ventriculomyotomy in muscular subaortic stenosis
163. Left ventricular compliance: Mechanisms and clinical implications
164. Diastolic properties of the left ventricle
165. The functional anatomy of ventricular contraction
166. De subitaneis mortibus: XII. Asymmetrical hypertrophy of the heart
167. Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis
168. Systolic constriction of the coronary arteries in hypertrophic cardiomyopathy
169. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis
170. Myocardial ischemia in hypertrophic cardiomyopathy: Contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures
171. Apical hypertrophic cardiomyopathy: Clinical and metabolic studies
172. Electrical activation of ventricles and interventricular septum in hypertrophic obstructive cardiomyopathy
173. Diastolic abnormalities of hypertrophic cardiomyopathy reproduced by asynchrony of the left ventricle in conscious dogs
174. Influence of asynchronous early diastolic left ventricular relaxation on diastolic function
175. Effects of verapamil on myocardial systolic and diastolic function during calcium overload
176. The pericardium substantially affects the left ventricular diastolic pressure-volume relationship in the dog
177. Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle
178. Pericardial pressure assessed by right atrial pressure: A basis for calculation of left ventricular transmural pressure
179. Assessment of pericardial constraint in dogs
180. Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy
181. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy
182. Acute effects of nifedipine on diastolic dysfunction in nonobstructive hypertrophic cardiomyopathy
183. Relaxation abnormalities in hypertrophic cardiomyopathies
184. Angina in idiopathic hypertrophic subaortic stenosis. A clinical correlate of regional left ventricular dysfunction: A videometric and echocardiographic study
185. Correlations of electrocardiographic pattern, shape of ventricular septum, and isovolumetric relaxation time in irregular hypertrophic cardiomyopathy (obstructive cardiomyopathy)
186. Relation between electrocardiographic repolarization change and mechanical events in left ventricular hypertrophy
187. Noninvasive assessment of left ventricular relaxation and filling by pulsed echocardiography in hypertrophic cardiomyopathy
188. Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine
189. Improved left ventricular diastolic properties in hypertrophic cardiomyopathy treated with nifedipine: Altered loading or improved muscle inactivation
190. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy
191. Left ventricular hypertrophy by ECG in hypertrophic cardiomyopathy
192. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy
193. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
194. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis
195. Ventricular tachycardia and degree of left ventricular hypertrophy in hypertrophic cardiomyopathy
196. Electrocardiogram predicts ventricular tachycardia in hypertrophic cardiomyopathy
197. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis
198. Relation between echocardiographically determined left atrial size and atrial fibrillation
199. Effects of operation on left atrial size and the occurrence of atrial fibrillation in patients with hypertrophic subaortic stenosis
200. Clinical aspects of cardiomyopathy
201. Two types of intraventricular pressure difference in the same patient. Left ventricular catheter entrapment and right ventricular outflow tract obstruction
202. Left ventricular function in cardiomyopathy
203. Left ventricular-aortic conduit for relief of midventricular obstruction
204. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy)
205. Latent muscular subaortic stenosis
206. Operative treatment in hypertrophic subaortic stenosis: Techniques, and the results of pre- and postoperative assessments in 83 patients
207. Disopyramide: Hemodynamic effects in hypertrophic cardiomyopathy
208. Evaluation of chronic nifedipine therapy in nonobstructive hypertrophic cardiomyopathy
209. Diltiazem-induced decrease of exercise-elevated pulmonary arterial diastolic pressure in hypertrophic cardiomyopathy patients
210. Improvement in left ventricular diastolic function during intravenous and oral diltiazem therapy in patients with hypertrophic cardiomyopathy: An echocardiographic study
211. Treatment of hypertrophic obstructive cardiomyopathy with verapamil
212. Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects
213. Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status
214. Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
215. Verapamil: Its potential for causing serious complications in patients with hypertrophic cardiomyopathy
216. Hypertrophic cardiomyopathy therapy with slow channel-inhibiting agents
217. Diastolic function in hypertrophic cardiomyopathy: Effects of propranolol and verapamil on diastolic stiffness
218. Hemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy
219. Muscular Subaortic Stenosis. Hemodynamic and clinical improvement after disopyramide
220. Cardioselective beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy
221. Long-term medical management of hypertrophic obstructive cardiomyopathy
222. Long-term propranolol therapy in muscular subaortic stenosis
223. The treatment of muscular subaortic stenosis
224. Propranolol in management of muscular subaortic stenosis
225. The surgical management of obstructive cardiomyopathy
226. Surgical treatment of idiopaothic hypertrophic subaortic stenosis: Technic and hemodynamic results of subaortic ventriculomyotomy
227. Surgical relief of diffuse subvalvular aortic stenosis
228. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis
229. Effect of septal myotomy and myectomy on left ventricular systolic function at rest and during exercise in patients with IHSS
230. Exercise performance after septal myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy
231. Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: Efficacy of ventricular septal myotomy and myectomy
232. Hypertrophic obstructive cardiomyopathy: 10–21 year follow-up after partial septal myectomy
233. Surgical resection in idiopathic hypertrophic subaortic stenosis with a combined approach through aorta and left ventricle
234. Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and nonobstructive cardiomyopathy
235. Laser myoplasty for hypertrophic cardiomyopathy In vitro experience in human postmortem hearts and in vivo experience in a canine model (transarterial) and human patients (intraoperative)
236. Results of operation for obstructive idiopathic subaortic stenosis
237. Single and two-dimensional echocardiographic visualization of the effects of septal myectomy in idiopathic hypertrophic subaortic stenosis
238. Effect of treatment of echocardiographic findings in muscular subaortic stenosis
239. Diffuse Muscular Subaortic Stenosis: Surgical treatment
240. Hypertrophic obstructive cardiomyopathy: Patterns of progression
241. Prognosis and mortality of hypertrophic obstructive cardiomyopathy
242. Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history
243. Congestive and hypertrophic cardiomyopathies
244. The course in idiopathic hypertrophic subaortic stenosis
245. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy
246. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy
247. Hypertrophic cardiomyopathy in infants: Clinical features and natural history
248. Sudden death in young athletes
249. Sudden death in patients with hypertrophic cardiomyopathy: Characterization of 26 patients without functional limitation
250. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiograpohic and hemodynamic features
251. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy
252. Vulnerability of patients with obstructive hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room. Analysis of 17 patients
253. Syncope in hypertrophic cardiomyopathy
254. Two-dimensional echoscardiographic findings during syncopal attack due to obstruction in the outflow tract of the left ventricle in a patient with hypertrophic obstructive cardiomyopathy
255. Syncope in hypertrophic obstructive cardiomyopathy due to asystole
256. Muscular subaortic stenosis associated with complete heart block
257. Sudden death in hypertrophic cardiomyopathy: Associated accessory atrioventricular pathways
258. Prognosis in hypertrophic cardiomyopathy
259. Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta-adrenergic blocking therapy
260. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries
261. Abnormal vascular responses to exercise in patients with aortic stenosis
262. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy
263. Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy
264. Progression to left ventricular dilation in patients with hypertrophic obstructive cardiomyopathy
265. Progression from hypertrophic obstructive cardiomyopathy to congestive cardiomyopathy in a child
266. Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy
267. Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy An echocardiographic study